First Header Logo Second Header Logo

Connection

Louis Koman to Muscle Spasticity

This is a "connection" page, showing publications Louis Koman has written about Muscle Spasticity.
Connection Strength

1.609
  1. Koman LA, Smith BP, Williams R, Richardson R, Naughton M, Griffin L, Evans P. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin. J Hand Surg Am. 2013 Mar; 38(3):435-46.e1.
    View in: PubMed
    Score: 0.436
  2. Norris JA, Cabrera MN, Smith TL, Reeves SH, Koman LA. Quantifying spasticity in a clinical setting. Biomed Sci Instrum. 2007; 43:284-9.
    View in: PubMed
    Score: 0.284
  3. Koman LA, Paterson Smith B, Balkrishnan R. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin. Paediatr Drugs. 2003; 5(1):11-23.
    View in: PubMed
    Score: 0.216
  4. Koman LA, Mooney JF, Smith BP, Walker F, Leon JM. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop. 2000 Jan-Feb; 20(1):108-15.
    View in: PubMed
    Score: 0.175
  5. Koman LA, Mooney JF, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop. 1993 Jul-Aug; 13(4):489-95.
    View in: PubMed
    Score: 0.112
  6. Kolaski K, Ajizian SJ, Passmore L, Pasutharnchat N, Koman LA, Smith BP. Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population. Am J Phys Med Rehabil. 2008 Jul; 87(7):556-66.
    View in: PubMed
    Score: 0.079
  7. Koman LA, Smith BP, Shilt JS. Cerebral palsy. Lancet. 2004 May 15; 363(9421):1619-31.
    View in: PubMed
    Score: 0.059
  8. Balkrishnan R, Manuel JC, Smith BP, Camacho FT, Koman LA. Longitudinal examination of health outcomes associated with botulinum toxin use in children with cerebral palsy. J Surg Orthop Adv. 2004; 13(2):76-80.
    View in: PubMed
    Score: 0.058
  9. Mooney JF, Koman LA, Smith BP. Pharmacologic management of spasticity in cerebral palsy. J Pediatr Orthop. 2003 Sep-Oct; 23(5):679-86.
    View in: PubMed
    Score: 0.056
  10. Ma J, Smith BP, Smith TL, Walker FO, Rosencrance EV, Koman LA. Juvenile and adult rat neuromuscular junctions: density, distribution, and morphology. Muscle Nerve. 2002 Dec; 26(6):804-9.
    View in: PubMed
    Score: 0.054
  11. Koman LA. Cerebral palsy: past, present, and future. J South Orthop Assoc. 2002; 11(2):93-101.
    View in: PubMed
    Score: 0.050
  12. Koman LA, Mooney JF, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop. 1994 May-Jun; 14(3):299-303.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.